LO FRANCIS sold $3.2M of ADPT
LO FRANCIS (Chief People Officer) sold 115,406 shares of Adaptive Biotechnologies Corp (ADPT) at an average of $28.06 ($28.02–$28.57, $3.24M total) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The sale reduces insider ownership, which may be interpreted as a slight negative signal, but the size is modest relative to market cap.
Market read
A routine insider sale with modest dollar amount; limited trading relevance.
What to watch
Potential upcoming corporate actions or compensation plans not disclosed could influence the insider's decision.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.
Ticker impact
Chief People Officer sold 115,406 shares for $3.24M via a 10b5‑1 plan, reducing holdings to 220,867 shares.
Potential modest downside pressure of 1‑2% in the next trading session.
A $3.2M sale by a senior officer is material but not large enough to trigger a sharp move; market may view it as routine.
Market effects
Minimal impact on the biotech sector; insider sales are common and unlikely to shift sector sentiment.
No regional effect; the filing is US‑specific.
Negligible on a global scale.
Counterpoint
The sale could be a portfolio rebalancing unrelated to company outlook, so price may remain stable.
Key entities
- CompanyAdaptive Biotechnologies Corp
Biotech firm listed on NASDAQ under ticker ADPT.
- ExecutiveLo Francis
Chief People Officer of Adaptive Biotechnologies.
